Childhood Cancer Therapeutic Catalyst

This scheme aims to de-risk early therapeutic opportunities to facilitate further drug discovery activity.

 Activity that would be considered eligible for support through this award includes:

• deconvolution and validation of novel targets and pathways 
• novel therapeutic approaches to validated targets 
• target identification projects (including development of platforms, assays and screens)  
• drug discovery feasibility and de-risking 

Funding: £250,000 total 

Duration: 18 months 

Research Authority due date: 25.3.26

Preliminary submission (required) due date: 10.4.26

Final proposal due date: TBD